Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6da63414676bf80aab3c91256c83c479 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef40fa751f0a68b56ee5ede09ddf99aa http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b93bfcccf43a7b3345ac4094375ed0f3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6e6b4947dd3b31382672f06931662b88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bab678f6e9a0c2538f1fd59780b37e2f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9cd612e7eb94f3550ed8562b636b199f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6bcaef89927d80bef9722adda71ea6ba |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-17 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C229-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C227-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C229-30 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C209-00 |
filingDate |
2008-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e24aba123aae4395e93b9fc2ba5d2f6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcb2dc70b03973a4044e44560e19ceaa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dda796dadb375ae10faa0a836e4ebb22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6af15486dae6c52c24ee4468f132e75 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e48393143e704918a35fd1fb0232f1b0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_039fe1a31dc45e33caf0ba64c7437c50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3cd2eb025f7f26fdc4aed43a054d468a |
publicationDate |
2009-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2009137842-A1 |
titleOfInvention |
Pregabalin -4-eliminate, pregabalin 5-eliminate, their use as reference marker and standard, and method to produce pregabalin containing low levels thereof |
abstract |
The present invention provides 3-(aminomethyl)-5-methylhex-4-enoic acid (Pregabalin-4-eliminate or PRG-4E) and 3-(aminomethyl)-5-methylhex-5-enoic acid (Pregabalin-5-eliminate or PRG-5E), and their uses as reference markers and standards for determining the purity of Pregabalin. The invention also provides a method to produce Pregabalin containing low levels of these impurities. |
priorityDate |
2007-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |